Corvus Pharmaceuticals, Inc. Rental Income, Nonoperating
Corvus Pharmaceuticals, Inc. (CRVS) reported Rental Income, Nonoperating of $78.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-25.
Financial Statements › Income Statement › Other Income
us-gaap:RentalIncomeNonoperating · last filed 2025-03-25
- Corvus Pharmaceuticals, Inc. rental income, nonoperating for fiscal 2023 was $78.00K, a 86.71% decline from fiscal 2022.
- Corvus Pharmaceuticals, Inc. rental income, nonoperating for fiscal 2022 was $587.00K.
| Period end | Rental Income, Nonoperating 12 month |
|---|---|
| 2023-12-31 | $78.00K 10-K · filed 2025-03-25 |
| 2022-12-31 | $587.00K 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |